The American College of Radiology Imaging Network (ACRIN) is an international imaging cooperative group, headquartered in Philadelphia, PA with biostatistical and data management headquartered in Providence, RI at Brown University. It is sponsored by the Cancer Imaging Program (CIP), Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute (NCI), as well as philanthropies.
ACRIN's goal is - through clinical trials of focused screening, diagnostic imaging, imaging biomarkers, and image-guided therapeutic technologies - to generate information that will lengthen and improve the quality of the lives of cancer patients. ACRIN's clinical trials address both existing and emerging technologies as they apply to cancer screening, diagnosis, staging, imaging as a biomarker, and image-guided treatment. Imaging clinical trials conducted by ACRIN are carefully designed for statistical validity. Protocols and concepts are reviewed and approved by the Cancer Imaging Program, NCI Steering Committees, and the Protocol Review Committee of the Clinical Trials Evaluation Program (CTEP).
NOTE: As NCI continues to transform the clinical trials system and respond to the Institute of Medicine’s recommendations focused on the creation of a highly integrated, national clinical trials network, several NCI sponsored Clinical Cooperative Groups have reorganized as they prepare to submit applications to the highly anticipated Request for Applications (RFA) that will outline the new National Clinical Trials Network (NCTN).
The American College of Radiology Imaging Network (ACRIN) and the Eastern Cooperative Oncology Group (ECOG) announced the name of the two organizations’ combined clinical research alliance: ECOG-ACRIN Cancer Research Group (ECOG-ACRIN). The announcement was made on September 22 at the 2011 ACRIN Annual Meeting. The newly formed entity blends the complementary strengths of each legacy organization, with research focused on the full cancer care continuum. http://www.acrin.org/ADMINISTRATION/COMMUNICATIONS.aspx